
GI Medical Oncologist @DanaFarber | Alumna of @MGHMedRes @HarvardChanSPH @TuftsMedSchool | views my own
Boston, MA
Joined March 2019
- Tweets70
- Following245
- Followers305
- Likes880
Sara K. Char, MD, MPH retweeted
Jo Henderson was just 17 years old when she was diagnosed with advanced colorectal cancer. As a patient of @KimmieNgMD at @DanaFarber, Dr. Ng weighs in with @NBCNews to share Jo's cancer journey and the rise of young-onset CRC in young adults and teens.
youtu.be/TTxHSEgcdxs?si=2caL…
Sara K. Char, MD, MPH retweeted
Brian Wolpin, MD, MPH, presents positive results from the RASolute 302 trial showing a substantial prolongation of survival for patients with previously treated metastatic pancreatic cancer, regardless of RAS mutation status, taking daraxonrasib, an investigational oral RAS(ON) multi-selective inhibitor, compared with chemotherapy. #ASCO26
Sara K. Char, MD, MPH retweeted
Cheers, chills, and a standing ovation when RASolute 302 showed unprecedented survival on daraxonrasib for patients with progressive pancreatic cancer
Seldom do you sense you’re witnessing a historic moment in cancer care but this feels like ras targeting has arrived
#ASCO26
Sara K. Char, MD, MPH retweeted
"New Game-Changing Pancreatic Cancer Treatment" - Dr. Brian Wolpin of @DanaFarber sits down with Erika Edwards and NBC Nightly News to discuss a new hope for treating pancreatic cancer. Dr. Wolpin presented the study results to a standing ovation today at #ASCO26.
nbcnews.com/nightly-news/vid…
@NBCNews @DanaFarber_Hale
Sara K. Char, MD, MPH retweeted
Just published in @NEJM: RAS(ON) Inhibitor daraxonrasib shows promising results in advanced pancreatic cancer phase 1/2 study. @DanaFarber's Dr. Brian Wolpin, director of @DanaFarber_Hale, is a lead investigator on the trial. Read more: bit.ly/4uvpS8w
Sara K. Char, MD, MPH retweeted
On International Women's Day, we're proud to say the Young-Onset Colorectal Cancer Center is a team led by women and founded by @KimmieNgMD. We are dedicated to our mission of understanding the unique needs of our young patients and advancing research to understand the rise. #InternationalWomensDay
Sara K. Char, MD, MPH retweeted
“It’s the craziest time in your life and throw cancer in and it’s a lot, I couldn’t do it without my Dana-Farber team" said @KimmieNgMD's young-onset colon cancer patient, John Veale, on @7News. Watch the full video here!
whdh.com/7-investigates/7-in…
Sara K. Char, MD, MPH retweeted
The Gastrointestinal Cancer Center decked out in blue today for #NationalDressinBlueDay for colorectal cancer awareness!💙 #Colorectalcancer
📸@johnsonphotog
Sara K. Char, MD, MPH retweeted
For the month of March, the healing garden at @DanaFarber will be lit up blue every night in honor of colorectal cancer awareness month.💙 #ColorectalCancerAwarenessMonth #March #ColorectalCancer @KimmieNgMD
Sara K. Char, MD, MPH retweeted
Colorectal cancer is the deadliest cancer in people under 50 and the second deadliest overall. Spreading awareness is important because many cases of colorectal cancer are preventable with screening. #Colorectalcancer #March
Sara K. Char, MD, MPH retweeted
We are deeply saddened to learn the news of James Van Der Beek's passing of colorectal cancer at age 48. Our hearts go out to his family during this difficult time.
today.com/popculture/news/ja…
Sara K. Char, MD, MPH retweeted
Join the Young-Onset Colorectal Cancer Center on Saturday, March 7, at @DanaFarber for our 7th annual Patient and Family Forum, a day of learning, connecting with fellow patients and caregivers, and building community. In-person and virtual options are available. We’d love to see you! #YOCRC #ColorectalCancer #DanaFarber
Register here: redcap.link/7thannualpatient…
Sara K. Char, MD, MPH retweeted
"We're interested in the role of modifiable factors and what patients can take on themselves to try and decrease their risk of cancer" says @KimmieNgMD in her recent interview along with @SaraKCharMD for @DanaFarber @DanaFarberNews.
dana-farber.org/newsroom/fea…
Sara K. Char, MD, MPH retweeted
Colorectal cancer is now the leading cause of cancer death in adults younger than 50, according to @AmericanCancer researchers. @DanaFarber's Dr. Jeff Meyerhardt tells the @WSJ that prevention and early detection are critical in efforts to reverse this alarming trend. @DFarberYoungCRC
➡️ bit.ly/4sZzFUE
Sara K. Char, MD, MPH retweeted
Featured in @CancerTodayMag, Dr. Sara Char discusses @DanaFarber research that looks at the impact of pro- and anti-inflammatory diets on colon cancer outcomes.
➡️ bit.ly/48QeRFS
Sara K. Char, MD, MPH retweeted
Team Beyond CRC at this year's Jimmy Fund Walk! We are so grateful to have such an amazing team walking and fundraising for the Jimmy Fund and the Young-Onset Colorectal Cancer Center. @TheJimmyFund @DanaFarber @KimmieNgMD
Sara K. Char, MD, MPH retweeted
It was a beautiful day for the Jimmy Fund Walk! We are honored to announce that Team Beyond CRC is one of the top fundraising teams this year! Thank you so much to all who have donated or participated. 💙 @TheJimmyFund @KimmieNgMD
Sara K. Char, MD, MPH retweeted
Recently released ASCO’s new #integrativeoncology guideline for GI cancers is free to access! Explore evidence based recommendations on acupuncture, mind-body therapies, and more to support symptom relief and quality of life in gastrointestinal cancers
ascopubs.org/doi/10.1200/EDB…
Sara K. Char, MD, MPH retweeted
What Age Is the Best “FIT” for Colorectal Cancer Screening? jamanetwork.com/journals/jam…
Thankful for the opportunity to write this editorial with @KimmieNgMD and @AndyChanMD @DFarberYoungCRC @MGH_CTEU @DanaFarberNews
Sara K. Char, MD, MPH retweeted
A new report from @DanaFarber highlights rising rates of GI cancers in young adults - not just #colorectal, but also #pancreatic, #esophageal, #gastric, #biliary & more. @DFarberYoungCRC @KimmieNgMD @SaraKCharMD @CatherineaOC
Read more: bit.ly/40D0kd8


















